Table 1.
Enzymatic dissociation strategies and applications of nuclei from FFPE tissues.
Tissues | Thickness | Protease | Time | Application | References |
---|---|---|---|---|---|
tumor | 30 μm | 0.5% pepsin | 30 min | DNA content | [17] |
brain, lung, breast, testis, kidney, and colon tumor | 50 μm | 0.5% pepsin | 30 min | ISH | [18] |
—— | 50 μm | 0.5% pepsin | 30 min | FISH | [19] |
brain | —— | 0.5% pepsin | 30 min | FISH | [21] |
breast, ovary, tumor | 40 μm | 0.005% pepsin | 2 h | FISH | [22] |
tumor | —— | 0.25% trypsin | Overnight | DNA ploidy | [23] |
—— | 20–30 μm | 0.005% PK | 30 min | FISH | [20] |
HNSCC | 5 μm | PK | 1 h | FISH | [24] |
lymph nodes, tonsils | —— | 0.01% PK | 2 h | ISH, FISH | [27] |
liver cancer | 10 μm | 0.005% PK | 2 h | FISH | [28] |
breast, brain, bladder, ovarian, and pancreas | 40–60 μm | collagenase, hyaluronidase | Overnight | aCGH, WES | [25] |
breast cancer | 100 μm | 16 h | sn-WGSA | [26] |
PK: proteinase K; ISH: in situ hybridization; FISH: fluorescence in situ hybridization; aCGH: array comparative genomic hybridization; WES: whole-exome sequencing; sn-WGSA: single-nucleus whole-genome DNA copy number; HNSCC: head and neck squamous cell carcinoma.